Cycloserine

环丝氨酸

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameCycloserine
Drug Alias NameSeromycin赛来星NSC-76029NSC-154851
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionD-alanine--D-alanine ligase A inhibitorsAlanine racemase inhibitors
TargetsD-alanine--D-alanine ligase AAlanine racemase
Therapy Area/IndicationsStress Disorders, Post-TraumaticSchizophreniaBorderline Personality Disorder +[35] 
Global Approved IndicationsTuberculosis, Pulmonary
Approved Indications in ChinaTuberculosis, Pulmonary
Original Approved Country/TerritoryUnited States
Original Approved Date1964/06/29
Country/TerritoryCanadaUnited StatesGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPurdue Pharma
China Registration ClassN/A

Develop Information

Active CompaniesPurdue PharmaMclean HospitalUniversity Of Calgary +[4] 
Inactive CompaniesWeill Medical College of Cornell UniversityUniversity Of ManitobaUniversity Of Minnesota +[25] 
Active IndicationsBorderline Personality DisorderObsessive-Compulsive DisorderMotor Activity +[4] 
Inactive IndicationsStress Disorders, Post-TraumaticSchizophreniaDevelopmental Disabilities +[31] 

Other Information

ATC CodeJ04AB01
Related LinksWikipediaDrugBankKEGG